Australia's largest stock trading and investment forum Australia's #1 stock forum

DXB

Click for more information

3.80%

41.0¢ dimerix limited

Ann: AusBioInvest Presentation, including FSGS recruitment update, page-9

First 9 Last

Share
Profile

Follow
singhgu

2,011 Posts.

455

04/11/22

11:19

Post #: 64587439
Share

Originally posted by ajc40: ↑

I received an answer from the company today regarding the timing question asked above. To paraphrase, and consistent with their messaging to date, expectations are that recruitment completes in the coming weeks. Patients then enter the background medication stabilisation period – which can be up to 6 weeks (this timing is dependent on what background medications the patient is on and how long they have been on them prior to the trial, some may only need a couple of weeks and others the full 6 weeks). As such, the final date of data outcome is driven by the last patient being dosed (currently expected sometime between mid-November and mid-December), which means the 1st interim 35 week endpoint could be between July and August based on current recruitment rates – with date reported a couple of weeks later. As is always the case in clinical trials, timing is always subject to recruitment and thus they cannot be absolute until all patients have been dosed.

I hope that helps.

GLA

Expand

Thanks for reaching out to the company and sharing your response....

Given clarity around when to expect, I am sure they will find a non dilutive solution to cater for extra 3-6 months...it's all up and higher from here in my view unless markets are hit by recession

DXB Price at posting: 15.5¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

STK

Rogozna grows with gold equivalent grading 1.1g/t across 545.7m for Strickland

TTT

Titomic jumps +6% as it incorporates Microsoft Hololens tech

RCE

Recce progresses testing of gel to treat bacterial skin infections

LU7

The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour

AHK

Ark Mines provides strategic update following mining lease submission

There are more pages in this discussion • 7 more messages in this thread...

First 9 Last

Add DXB (ASX) to my watchlist

(20min delay)
Last 41.0¢		Change 0.015(3.80%)		Mkt cap ! $228.4M

Open	High	Low	Value	Volume
39.0¢	41.5¢	39.0¢	$1.181M	2.922M

Buyers (Bids)

No.	Vol.	Price($)
4	260640	40.5¢

Sellers (Offers)

Price($)	Vol.	No.
41.0¢	22838	1

View Market Depth

No.	Vol.	Price($)
4	260640	0.405
5	175640	0.400
1	22000	0.395
6	108922	0.390
4	120670	0.385

Price($)	Vol.	No.
0.410	22838	1
0.415	37039	1
0.420	48640	3
0.425	87440	4
0.430	64044	4

Last trade - 16.10pm 09/10/2024 (20 minute delay)

DXB (ASX) Chart

SPONSORED BY